Bayer AG BAYRY reported first-quarter 2026 core earnings of 79 cents per American Depositary Receipt (ADR), beating the Zacks ...

Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase 1 pipeline. The German pharma giant had already evaluated an atrial natriuretic ...

The NHS says that after you have called 999 to ask for help, taking 300mg of aspirin if you have it may be useful should you notice signs of a heart attack. Of course, this only applies if you don’t ...

Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that ...

Bayer BAYN0.55%increase; green up pointing triangle said it agreed to buy Perfuse Therapeutics for up to $2.45 billion, snapping up an eye-drug specialist that is developing a potential glaucoma ...

May 6 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Wednesday that it will ‌buy biopharmaceutical company Perfuse Therapeutics to complement its ophthalmology pipeline. The deal has a potential ...

Bayer's (BAYRY) (BAYZF) Monsanto unit agreed to pay at least $133M to settle claims by Michigan and Rhode Island that the company ‌contaminated the states' natural resources with toxic chemicals that ...

Bayer said it agreed to buy Perfuse Therapeutics, a pharmaceutical company that specializes in drugs for eye diseases, for up to $2.45 billion. The German pharmaceutical-and-agricultural group said ...

Plaintiffs' law firms say the fee is "modest" Settlement is moving toward final approval date in July Bayer has proposed $7.25 billion to settle Roundup cases May 12 (Reuters) - Class action lawyers ...

Collaboration to commercialize camelina for producing renewable diesel (RD) and sustainable aviation fuels (SAF) bp will bring expertise in fuel and refining, Bayer its expertise in seed technology ...